GSK

Q: What is the price of GlaxoSmithKline (GSK) today?

The current price of GlaxoSmithKline (GSK) is $ 58.42, representing a 76.17% gain over the past year. The stock began the year trading around $ 49.04 and is currently priced at $ 58.42. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does GlaxoSmithKline (GSK) pay dividends?

GlaxoSmithKline (GSK) distributed dividends in the last year,in the months of January and April totaling $ 0.90. The Dividend Yield for the last 12 months is 2.96%.

GlaxoSmithKline PLC

Price

$ 58.42

return (12m)

76.17%

p/e

14.82

p/bv

5.29

DIVIDEND YIELD

2.96%

GSK price

GSK

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment GSK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.45%

3 months

16.87%

1 year

76.17%

2 years

56.17%

5 years

149.30%

10 years

206.25%

Fundamentals GSK

review the fundamentals of GlaxoSmithKline shares

P/E

14.82

Sector: -2.15 Industry: 0.38

P/S (PSR)

2.59

Sector: 1.92 Industry: 2.43

P/BV

5.29

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

2.96%

Sector: - Industry: -

ROA

9.32%

Sector: -25.33% Industry: -23.48%

ROE

35.71%

Sector: -29.65% Industry: -31.19%

ROIC

6.84%

Sector: -418.66% Industry: -76.94%

NET MARGIN

17.48%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

72.39%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

24.26%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

7.13

Sector: -0.40 Industry: 1.11

EV/EBIT

10.46

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

1.38

Sector: 1.13 Industry: 1.20

BVPS

10.63

Sector: 3.83 Industry: 5.09

EPS

3.79

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

0.26

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.74

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

3.36%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

6.32%

Sector: - Industry: -

FAIR VALUE OF GlaxoSmithKline ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 58.42

Fair Value

$ 0.00

Upside/Downside Return potential.

-48.46%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GSK

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%
CI	10.45	0.00	0.00%	2.26%	$ 71.83 B	2.50%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

GSK Historical Dividends

current DY: 2.96%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/20/2026	04/09/2026	0,48560000
Dividends	11/14/2025	01/08/2026	0,40960000
Dividends	08/15/2025	10/09/2025	0,42810000
Dividends	05/16/2025	07/10/2025	0,42910000
Dividends	02/21/2025	04/10/2025	0,40060000
Dividends	11/15/2024	01/09/2025	0,38900000
Dividends	08/16/2024	10/10/2024	0,38570000
Dividends	05/17/2024	07/11/2024	0,37620000
Dividends	02/23/2024	04/11/2024	0,40610000
Dividends	11/17/2023	01/11/2024	0,33980000
Dividends	08/18/2023	10/12/2023	0,36130000
Dividends	05/19/2023	07/13/2023	0,34750000
Dividends	02/24/2023	04/13/2023	0,34040000
Dividends	11/18/2022	01/12/2023	0,31710000
Dividends	08/19/2022	10/06/2022	0,39080000
Dividends	05/20/2022	07/01/2022	0,34960000
Dividends	02/25/2022	04/07/2022	0,62210000
Dividends	11/19/2021	01/13/2022	0,52340000
Dividends	08/20/2021	10/07/2021	0,53010000
Dividends	05/21/2021	07/08/2021	0,52700000
Dividends	02/19/2021	04/08/2021	0,63670000
Dividends	11/13/2020	01/14/2021	0,49600000
Dividends	08/14/2020	10/08/2020	0,49290000
Dividends	05/15/2020	07/09/2020	0,47390000
Dividends	02/21/2020	04/09/2020	0,59900000
Dividends	11/15/2019	01/09/2020	0,48900000
Dividends	08/09/2019	10/10/2019	0,46580000
Dividends	05/17/2019	07/11/2019	0,49530000
Dividends	02/22/2019	04/11/2019	0,60170000
Dividends	11/16/2018	01/10/2019	0,48380000
Dividends	08/10/2018	10/11/2018	0,50110000
Dividends	05/11/2018	07/12/2018	0,53000000
Dividends	02/23/2018	04/12/2018	0,63800000
Dividends	11/10/2017	01/11/2018	0,50400000
Dividends	08/11/2017	10/12/2017	0,50100000
Dividends	05/12/2017	07/13/2017	0,49040000
Dividends	02/24/2017	04/13/2017	0,57120000
Dividends	11/04/2016	01/12/2017	0,46210000
Dividends	08/12/2016	10/13/2016	0,49900000
Dividends	05/13/2016	07/14/2016	0,55400000
Dividends	02/19/2016	04/14/2016	1,25200000
Dividends	11/13/2015	01/14/2016	0,58200000
Dividends	08/14/2015	10/01/2015	0,59300000
Dividends	05/15/2015	07/09/2015	0,57790000
Dividends	02/20/2015	04/09/2015	0,68540000
Dividends	11/07/2014	01/08/2015	0,60440000
Dividends	08/08/2014	10/02/2014	0,63910000
Dividends	05/16/2014	07/10/2014	0,63100000
Dividends	02/21/2014	04/10/2014	0,75000000
Dividends	11/15/2013	01/09/2014	0,60740000
Dividends	08/09/2013	10/03/2013	0,54540000
Dividends	05/10/2013	07/11/2013	0,54250000
Dividends	02/22/2013	04/11/2013	0,67980000
Dividends	11/16/2012	01/03/2013	0,57080000
Dividends	08/10/2012	10/04/2012	0,52050000
Dividends	05/11/2012	07/05/2012	0,54140000
Dividends	02/17/2012	04/12/2012	0,82100000
Dividends	11/04/2011	01/05/2012	0,53350000
Dividends	08/05/2011	10/06/2011	0,51200000
Dividends	05/06/2011	07/07/2011	0,51710000
Dividends	02/11/2011	04/07/2011	0,61500000
Dividends	10/29/2010	01/06/2011	0,49850000
Dividends	07/30/2010	10/07/2010	0,44920000
Dividends	05/07/2010	07/08/2010	0,45230000
Dividends	02/12/2010	04/08/2010	0,57400000
Dividends	11/06/2009	01/07/2010	0,48140000
Dividends	07/31/2009	10/08/2009	0,45290000
Dividends	05/01/2009	07/09/2009	0,40210000
Dividends	02/13/2009	04/09/2009	0,48590000
Dividends	10/31/2008	01/08/2009	0,46650000
Dividends	08/01/2008	10/09/2008	0,51000000
Dividends	05/02/2008	07/10/2008	0,50950000
Dividends	02/15/2008	04/10/2008	0,62700000
Dividends	11/02/2007	01/10/2008	0,52320000
Dividends	08/03/2007	10/11/2007	0,48600000
Dividends	05/04/2007	07/12/2007	0,47220000
Dividends	02/16/2007	04/12/2007	0,55200000
Dividends	11/03/2006	01/04/2007	0,44260000
Dividends	08/04/2006	10/05/2006	0,39920000
Dividends	05/12/2006	07/06/2006	0,38630000
Dividends	02/17/2006	04/06/2006	0,47890000
Dividends	11/04/2005	01/05/2006	0,34900000
Dividends	08/05/2005	10/06/2005	0,34170000
Dividends	05/13/2005	07/07/2005	0,37340000
Dividends	02/18/2005	04/07/2005	0,43660000
Dividends	11/05/2004	01/06/2005	0,35880000
Dividends	08/06/2004	09/30/2004	0,35950000
Dividends	05/14/2004	07/01/2004	0,34660000
Dividends	02/20/2004	04/15/2004	0,51080000
Dividends	10/31/2003	01/06/2004	0,29490000
Dividends	08/01/2003	10/02/2003	0,28130000
Dividends	05/09/2003	07/03/2003	0,31700000
Dividends	02/21/2003	04/17/2003	0,45700000
Dividends	11/01/2002	01/03/2003	0,30260000
Dividends	08/02/2002	10/03/2002	0,30590000
Dividends	05/03/2002	07/05/2002	0,55500000
Dividends	02/22/2002	04/18/2002	0,71500000
Dividends	11/02/2001	01/03/2002	0,27930000
Dividends	08/03/2001	10/04/2001	0,27790000
Dividends	05/04/2001	07/05/2001	0,28230000
Dividends	12/26/2000	04/27/2001	0,74200000
Dividends	08/11/2000	10/26/2000	0,50200000
Dividends	03/03/2000	06/05/2000	0,78500000
Dividends	08/13/1999	10/12/1999	0,53970000
Dividends	03/05/1999	06/01/1999	0,59500000
Dividends	08/14/1998	10/13/1998	0,49980000
Dividends	03/06/1998	06/01/1998	0,65200000
Dividends	08/15/1997	12/02/1997	0,49100000
Dividends	03/21/1997	05/30/1997	0,72700000
Dividends	08/20/1996	10/11/1996	0,58400000
Dividends	03/26/1996	05/30/1996	0,58000000
Dividends	09/26/1995	11/02/1995	0,77400000
Dividends	03/02/1995	04/20/1995	0,38500000

ABOUT GlaxoSmithKline

GlaxoSmithKline PLC

Average Investor10 user rating

5.0 (79 people)

United States

27 years

Founded: 1999

1987

Time since IPO - 39 years

90.090

Employees

GSK plc operates in the Healthcare sector, within the Biopharmaceutical industry. The company develops and commercializes prescription medicines and vaccines across multiple therapeutic areas.

Its portfolio focuses on:

Immunology.
Respiratory diseases.
HIV treatments.
Oncology.
Infectious diseases and vaccines.

GSK operates globally, with the United States representing a key commercial market. The company maintains research centers, manufacturing facilities, and commercial operations across major regions.

Performance is influenced by drug development cycles, regulatory approvals, patent protection, vaccine demand, pricing dynamics, and competition within the global pharmaceutical industry.

GSK plc shares trade on the New York Stock Exchange (NYSE) under the ticker GSK.

History and Development

GSK was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, combining two established pharmaceutical companies with extensive research capabilities.

Over the following decades, the company expanded its vaccine portfolio, strengthened its presence in specialty medicines, and entered multiple strategic partnerships.

In recent years, GSK streamlined its corporate structure, separated its consumer healthcare business, and increased focus on vaccines, immunology, and infectious disease therapies, reinforcing its positioning as a research-driven biopharmaceutical company.

Additional Information

GlaxoSmithKline PLC (United States) is listed on the NYSE and has a market capitalization of $113.04 Billions, with shareholders equity totaling $21.36 Billions.

The company employs approximately 90.090 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, GlaxoSmithKline PLC reported $43.63 Billions in revenue, generating net income of $7.63 Billions.

Key financial metrics include a P/E ratio of 14.82, a price-to-book (P/B) ratio of 5.29, and a trailing twelve-month dividend yield of 2.96%.

The company trades under the ticker GSK.

Market cap

$ 113.04 Billions

Net worth

$ 21.36 Billions

$ 21,360,110,000.00

Assets

$ 81.82 Billions

$ 81,817,940,000.00

Total Shares Outstanding

2.01 Billions

2,010,000,000

Average Daily Trading Volume

$ 5.67 Millions

$ 5,665,867.68

Sector

Health

Industry

Pharmaceutical Products

GSK

revenue by Business Segment GlaxoSmithKline

Revenue by Region GlaxoSmithKline

GSK revenue and profits

Financial Results GSK

DRAG THE FRAME TO SEE MORE DATA

GSK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.16 20,24% (12 M)

P/L

52.79

3.62%

ROE

2.35%

P/VP

1.24

CI - Cigna

$ 278.37 --13,14% (12 M)

P/L

10.45

2.26%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 37.27 --40,26% (12 M)

P/L

-2.59

0.00%

ROE

-33.28%

P/VP

0.86

HUM - Humana

$ 197.45 --30,67% (12 M)

P/L

17.96

1.99%

ROE

6.70%

P/VP

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12 M)

P/L

15.86

0.62%

ROE

-244.82%

P/VP

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12 M)

P/L

40.57

0.67%

ROE

86.53%

P/VP

35.11

NVS - Novartis

$ 155.47 58,82% (12 M)

P/L

21.09

4.53%

ROE

30.04%

P/VP

6.34

Frequently Asked Questions

What is the price of GlaxoSmithKline (GSK) today?

The current price of GlaxoSmithKline (GSK) is $ 58.42, representing a 76.17% gain over the past year. The stock began the year trading around $ 49.04 and is currently priced at $ 58.42. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does GlaxoSmithKline (GSK) pay dividends?

GlaxoSmithKline (GSK) distributed dividends in the last year,in the months of January and April totaling $ 0.90. The Dividend Yield for the last 12 months is 2.96%.

Is GlaxoSmithKline (GSK) a good investment?

GlaxoSmithKline (GSK) is currently trading at $ 58.42 with a P/E ratio of 14.82%. This represents a 1,235% premium compared to its historical average P/E. Over the past year, the stock has gained 76.17 and paid $ 0.90 in dividends, resulting in a dividend yield of 2.96%. The total shareholder return over the same period was 76.17%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy GlaxoSmithKline (GSK) stock?

You can buy GlaxoSmithKline (GSK) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol GSK and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of GlaxoSmithKline (GSK) yield today?

Over the past month, GlaxoSmithKline (GSK) has returned 6.45% — 76.17% over the past year, and 149.30% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 1.75 per share in dividends, resulting in a dividend yield of 2.96%.

If you were to purchase 100 shares of GlaxoSmithKline (GSK) today at the current price of $ 58.42 your total investment would be $ 5,842.00.

Based on historical performance, the investment would have grown to approximately:

$ 10,291.85 after 1 year
$ 14,564.11 after 5 years
$ 17,891.13 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

GSK

GlaxoSmithKline PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GSK

review the fundamentals of GlaxoSmithKline shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 2.96%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT GlaxoSmithKline

GlaxoSmithKline PLC

United States

27 years

1987

90.090

History and Development

Additional Information

PROFIT X PRICE GSK

Financial Results GSK

GSK cash flow

Asset, Revenue and Profit Growth - GSK

GSK balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions